ProCE Banner Activity

Key Decisions in HIV Care: Choosing Initial ART in PWH With Transmitted Drug Resistance

Podcast Episodes
Listen as John D. Baxter, MD, shares the latest data and recommendations for initiating ART in patients with transmitted antiretroviral drug resistance.

Released: January 25, 2022

Expiration: January 24, 2023

Share

Faculty

John D. Baxter

John D. Baxter, MD

Professor of Medicine
Division of Infectious Diseases
Department of Pathology
Cooper Medical School of Rowan University
Head, Division of Infectious Diseases
Cooper University Health Care
Camden, New Jersey

Supporters

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

ViiV Healthcare

Faculty Disclosure

Primary Author

John D. Baxter, MD

Professor of Medicine
Division of Infectious Diseases
Department of Pathology
Cooper Medical School of Rowan University
Head, Division of Infectious Diseases
Cooper University Health Care
Camden, New Jersey

John D. Baxter, MD, has no relevant conflicts of interest to report.